SecBot SecBot
S-3 ·Filed Jun 4, 2026

QUCY

Quantum Cyber N.V.
BEARISH
Impact 7/10
Horizonweeks Processed4mo ago SEC0001213900-26-064908
Shelf registration — potential dilution
Actionable Insight ▼ Bearish

Expect significant dilution over the coming months as the company taps this shelf to fund operations and its pivot to drone technology. The going-concern warning and zero-revenue profile make any equity issuance highly dilutive. Monitor for prospectus supplements that will reveal actual offering size, pricing, and structure — likely an ATM or registered direct offering at a discount to market.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
QUCY ▼ -39.06% at T+60d
SHORT call ✓ call won +39.06% · α vs SPY +40.94% · entry $2.33 → $1.42
Entry = T+0 close
Jun 4, 2026
via day close
T+1d
-5.58%
call +5.58% · α +2.98%
$2.20
settled 5mo ago
T+5d
-18.45%
call +18.45% · α +15.90%
$1.90
settled 5mo ago
T+20d
-37.77%
call +37.77% · α +36.40%
$1.45
settled 4mo ago
T+60d
-39.06%
call +39.06% · α +40.94%
$1.42
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Quantum Cyber N.V. filed a universal shelf registration statement on Form S-3 to register up to $250,000,000 in securities (ordinary shares, preferred shares, warrants, subscription rights, and/or units) for future sale. The company has no revenue, an accumulated deficit of ~$110M, and a going-concern qualification in its most recent 10-Q, making this a desperation capital raise to fund a pivot from cancer diagnostics to AI/quantum drone technology.

Key Financial Metrics

Offering Size
$250.0M

Key Facts

  • Shelf registration of up to $250,000,000 — ~4.5x current market cap of $56M
  • Zero revenue in Q1 2026; net loss of $5.1M; accumulated deficit of ~$110.0M
  • Going-concern qualification in the March 31, 2026 10-Q
  • Cash balance of $4.45M at quarter-end; operating cash burn of ~$2.7M in Q1 2026
  • Company pivoted from cancer diagnostics (Mainz Biomed) to AI/quantum drone technology in April 2026
  • Stock closed at $2.45 on June 2, 2026, down from $3.56 on May 21, 2026 (public float calculation date)

Financial Impact

Up to $250M in potential dilution — over 4x the current $56M market cap. The company has no revenue and is burning ~$2.7M/quarter in operating cash.

dilutionmarket_capcash_runway

Risk Factors

  • Massive dilution: $250M shelf is ~4.5x current market cap
  • Going-concern risk: company has no revenue, negative equity working capital, and substantial doubt about ability to continue
  • Business model pivot risk: transition from cancer diagnostics to AI/quantum drones is unproven with no revenue or contracts
  • Nasdaq listing risk: continued low share price could trigger minimum bid price compliance issues

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001213900-26-064908
Document: ea029338801ex5-1.htm0001213900-26-064908
Document: ea029338801ex-fee.htm0001213900-26-064908
Document: ea029338801ex5-2.htm0001213900-26-064908
Document: ea029338801ex23-1.htm0001213900-26-064908
Document: 0001213900-26-064908-index-headers.html0001213900-26-064908
Document: 0001213900-26-064908-index.html0001213900-26-064908
Document: 0001213900-26-064908.txt0001213900-26-064908
35 reports for QUCY
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 4 of 6 best @ T+20▲ +37.37%Jun 17, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
NEUTRAL ★ 2/10
$1.03awaiting T+20—$0.8520 (−17.28%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$1.07awaiting T+20—$0.8520 (−20.37%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$1.03awaiting T+20—$0.8520 (−17.28%)
Oct 9, 2026
17d ago
424B5
BEARISH ★ 7/10
$1.03awaiting T+20—$0.8520 (+17.28%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$1.36 $0.8515▼ −37.39%▼ −37.36%$0.8520 (−37.35%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$0.8520 (−37.81%)
Sep 25, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$0.8520 (−37.81%)
Aug 13, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$1.42 $1.34▼ −5.63%▼ −3.89%$0.8520 (−40.00%)
Jul 24, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$1.08 $1.30▲ +20.37%▲ +16.74%$0.8520 (−21.11%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$1.19awaiting T+20—$0.8520 (−28.40%)
Showing 10 of 35

US Market Status

Market Closed — Opens in 4h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 4, 2026